Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a "divide and conquer" strategy.

Source:http://linkedlifedata.com/resource/pubmed/id/11689071

J. Med. Chem. 2001 Nov 8 44 23 3849-55

Download in:

View as

General Info

PMID
11689071